Loading...
Oxygenta Pharmaceutical Ltd.
OXYGENTAPH.BO•BSE
Healthcare
Medical - Pharmaceuticals
₹47.99
₹1.33(2.85%)
Indian Market opens in 8h 4mOxygenta Pharmaceutical Ltd. (OXYGENTAPH.BO) AI-Powered Stock Analysis
See how Oxygenta Pharmaceutical Ltd. scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerOxygenta Pharmaceutical Ltd. (OXYGENTAPH.BO) Stock Overall Grade
Oxygenta Pharmaceutical Ltd.’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Oxygenta Pharmaceutical Ltd.'s overall stock rating.
Forecast
A+Score
98/100Financial Growth
CScore
40/100Fundamental Growth
C+Score
51/100Key Ratios
B+Score
70/100Sector Comparison
A+Score
100/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
94/100Analyst Consensus
C+Score
50/100Oxygenta Pharmaceutical Ltd. (OXYGENTAPH.BO) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 98/100 (A+), reflecting high confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (51/100, C+) highlight its stability, while Key Ratios (70/100, B+) and Sector Comparison (100/100, A+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (94/100, A+), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Oxygenta Pharmaceutical Ltd. stock grade, including financials, comparisons, and forecasts.